Hide metadata

dc.date.accessioned2014-02-18T15:52:54Z
dc.date.available2014-02-18T15:52:54Z
dc.date.created2014-01-30T13:00:24Z
dc.date.issued2013
dc.identifier.citationJenstad, Monica Chaudhry, Farrukh Abbas . The Amino Acid Transporters of the Glutamate/GABA-Glutamine Cycle and Their Impact on Insulin and Glucagon Secretion. Frontiers in Endocrinology. 2013, 4
dc.identifier.urihttp://hdl.handle.net/10852/38317
dc.description.abstractIntercellular communication is pivotal in optimizing and synchronizing cellular responses to keep homeostasis and to respond adequately to external stimuli. In the central nervous system (CNS), glutamatergic and GABAergic signals are postulated to be dependent on the glutamate/GABA-glutamine cycle for vesicular loading of neurotransmitters, for inactivating the signal and for the replenishment of the neurotransmitters. Islets of Langerhans release the hormones insulin and glucagon, but share similarities with CNS cells in for example transcriptional control of development and differentiation, and chromatin methylation. Interestingly, CNS proteins involved in secretion of the neurotransmitters and emitting their responses as well as the regulation of these processes, are also found in islet cells. Moreover, high levels of glutamate, GABA, and glutamine and their respective vesicular and plasma membrane transporters have been shown in the islet cells and there is emerging support for these amino acids and their transporters playing important roles in the maturation and secretion of insulin and glucagon. In this review, we will discuss the feasibility of recent data in the field in relation to the biophysical properties of the transporters (Slc1, Slc17, Slc32, and Slc38) and physiology of hormone secretion in islets of Langerhans.en_US
dc.languageEN
dc.language.isoenen_US
dc.rightsAttribution 3.0 Unported
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/
dc.titleThe Amino Acid Transporters of the Glutamate/GABA-Glutamine Cycle and Their Impact on Insulin and Glucagon Secretionen_US
dc.typeJournal articleen_US
dc.creator.authorJenstad, Monica
dc.creator.authorChaudhry, Farrukh Abbas
cristin.unitcode185,53,2,10
cristin.unitnameSenter for kreftbiomedisin
cristin.ispublishedtrue
cristin.fulltextoriginal
dc.identifier.cristin1104857
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Frontiers in Endocrinology&rft.volume=4&rft.spage=&rft.date=2013
dc.identifier.jtitleFrontiers in Endocrinology
dc.identifier.volume4
dc.identifier.doihttp://dx.doi.org/10.3389/fendo.2013.00199
dc.identifier.urnURN:NBN:no-41125
dc.type.documentTidsskriftartikkelen_US
dc.type.peerreviewedPeer reviewed
dc.source.issn1664-2392
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/38317/1/fendo-04-00199.pdf
dc.type.versionPublishedVersion
cristin.articleid199


Files in this item

Appears in the following Collection

Hide metadata

Attribution 3.0 Unported
This item's license is: Attribution 3.0 Unported